Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Market Cap	2.24B -18.6%
Revenue (ttm)	739.63M +6.7%
Net Income	-312.73M
EPS	-1.42
Shares Out	220.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,163,390
Average Volume	1,525,164
Open	10.21
Previous Close	10.20
Day's Range	10.09 - 10.27
52-Week Range	9.60 - 14.32
Beta	-0.16
RSI	38.89
Earnings Date	Feb 27, 2026

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, rapid antigen test kits, and automated nucleic acid (NA) extraction instruments in Turkey. It offers microbiology, genetic disorder, multiplex panel, drug resistance sequencing, food testing kits, as well as sample collection and transport; and full automation, manual magnetic bead NA extraction, and automated NA extraction instrument kits. The compan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 249
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ANGEN

Financial Performance

In 2025, IST:ANGEN's revenue was 739.63 million, an increase of 6.65% compared to the previous year's 693.51 million. Losses were -312.73 million, 9.16% more than in 2024.